Drugs / Epigenetically Modified Autologous Tumor
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01341496 | Apr 2011 → May 2016 | epithelial neoplasm, melanoma, pleural cancer, sarcoma | National Cancer Institute (NCI) | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Epigenetically Modified Autologous Tumor | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01341496 ↗ |
| Route | Intramuscular | “will be administered IM” NCT01341496 ↗ |